High-Dose IL-23 Inhibition Shows Promise for Psoriasis Remission in Early Study

Brasil Notícia Notícia

High-Dose IL-23 Inhibition Shows Promise for Psoriasis Remission in Early Study
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Medscape
  • ⏱ Reading Time:
  • 60 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 55%

The study is investigating whether high-dose IL-23 inhibition can target resident memory T cells and thereby induce long-term remission.

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.

The findings are interim results that pool the two doses of risankizumab . An evaluation of maintenance of efficacy with the 300-mg versus 600-mg doses and results of the skin biopsies will be presented at the 2024 annual meeting of the American Academy of Dermatology, he said. Patients who have not had recurrences are being followed up to week 100 .

"Resident memory T cells have been thought to be cells that are constrained to being resident in the tissue, and while that's largely true, there's more recent data showing that they actually can dedifferentiate and go back to the lymph node and then go back to the joint again," Dr. Ritchlin noted in an interview."So it's a more complicated story," but nonetheless targeting the cells is a concept worth exploring therapeutically.

During a discussion period, Dr. Blauvelt said that in a future iteration of the"knockout" study, he would like to evaluate risankizumab in patients with disease duration under 12 months. It may also be valuable to look not only at Trm cells, but more broadly at other elements of the tissue architecture before and after treatment.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Medscape /  🏆 386. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

2024 Porsche Cayenne E-Hybrid First Drive Review: High-End Choices for High-End SUVsThe new 2024 Porsche Cayenne SUV comes in six flavors, including these two powerful plug-in hybrid versions packing tons of horsepower.
Consulte Mais informação »

- The MCU's Shows Aren't Worse Than Marvel's Netflix Series- The MCU's Shows Aren't Worse Than Marvel's Netflix SeriesAlthough the MCU's Disney+ shows have received mixed reception online, the shows' statistics are actually better than Marvel's Netflix shows.
Consulte Mais informação »

Daily Dose: Dazy, “Forced Perspective”Daily Dose: Dazy, “Forced Perspective”On 'Forced Perspective,' Dazy returns with a familiar, enchanting ripple of '90s alt-pop and contemporary slacker rock.
Consulte Mais informação »

New study shows which neighborhoods police spend most time patrollingNew study shows which neighborhoods police spend most time patrollingUsing anonymized smartphone data from nearly 10,000 police officers in 21 large U.S. cities, research from Indiana University finds officers on patrol spend more time in predominantly Black and Hispanic neighborhoods.
Consulte Mais informação »

Adults With ADHD May Be 3 Times More Likely to Develop Dementia, Study ShowsAdults With ADHD May Be 3 Times More Likely to Develop Dementia, Study ShowsNew research found that adults with ADHD are nearly three times as likely to develop dementia. Researchers did not prove causation, simply a correlation between the mental health disorder and impacted cognitive function.
Consulte Mais informação »

Perovskite nanocrystalline cheaper than silicon for photovoltaic cells, study showsPerovskite nanocrystalline cheaper than silicon for photovoltaic cells, study showsNew research from Brock University is introducing a highly efficient material for solar panels that is significantly less expensive than the silicon currently dominating the industry.
Consulte Mais informação »



Render Time: 2025-02-28 21:01:17